Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hornedo

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Pharmacotherapy|March 1, 1985
Amsacrine (m-AMSA): a new antineoplastic agent. Pharmacology, clinical activity and toxicityJ Hornedo, D A Van Echo
Bone Marrow Transplantation|January 7, 1998
Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacyE Wasserman, M Hidalgo, J Hornedo, et al.
Medical and Pediatric Oncology|January 1, 1985
Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancerJ Z Fuks, H Patel, D A Van Echo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neckM Eisenberger, J Hornedo, H Silva, et al.
Postgraduate Medical Journal|August 1, 1989
Meningeal infiltration by non-myelomatous IgD-secreting plasma cell dyscrasiasM Yebra, L Manzano, A de la Torre, et al.
Medical and Pediatric Oncology|January 1, 1986
Infections in patients with non-small-cell lung cancer treated with intensive induction chemotherapyJ Z Fuks, H Patel, J Hornedo, et al.
British Journal of Cancer|July 2, 1999
Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative responseE Reyes, I García-Castro, F Esquivel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1983
Radiation therapy in craniopharyngiomasF A Calvo, J Hornedo, A Arellano, et al.
Seminars in Oncology|February 1, 1997
Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancerR Hitt, J Hornedo, R Colomer, et al.
Seminars in Oncology|December 1, 1995
A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary resultsR Hitt, J Hornedo, R Colomer, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Pharmacotherapy|March 1, 1985
Amsacrine (m-AMSA): a new antineoplastic agent. Pharmacology, clinical activity and toxicityJ Hornedo, D A Van Echo
Bone Marrow Transplantation|January 7, 1998
Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacyE Wasserman, M Hidalgo, J Hornedo, et al.
Medical and Pediatric Oncology|January 1, 1985
Vindesine and high-dose cisplatin in the treatment of advanced non-small-cell lung cancerJ Z Fuks, H Patel, D A Van Echo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
Carboplatin (NSC-241-240): an active platinum analog for the treatment of squamous-cell carcinoma of the head and neckM Eisenberger, J Hornedo, H Silva, et al.
Postgraduate Medical Journal|August 1, 1989
Meningeal infiltration by non-myelomatous IgD-secreting plasma cell dyscrasiasM Yebra, L Manzano, A de la Torre, et al.
Medical and Pediatric Oncology|January 1, 1986
Infections in patients with non-small-cell lung cancer treated with intensive induction chemotherapyJ Z Fuks, H Patel, J Hornedo, et al.
British Journal of Cancer|July 2, 1999
Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative responseE Reyes, I García-Castro, F Esquivel, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1983
Radiation therapy in craniopharyngiomasF A Calvo, J Hornedo, A Arellano, et al.
Seminars in Oncology|February 1, 1997
Study of escalating doses of paclitaxel plus cisplatin in patients with inoperable head and neck cancerR Hitt, J Hornedo, R Colomer, et al.
Seminars in Oncology|December 1, 1995
A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary resultsR Hitt, J Hornedo, R Colomer, et al.
Pageof 3